Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells

To produce marine-origin nanoparticles (NPs) aiming to develop more effective and tolerated therapies for breast cancer. NPs based in two marine-origin polymers (fucoidan and chitosan) were prepared by polyelectrolyte complexation, for the delivery of an antitumor drug model (gemcitabine [Gem]). Fin...

Full description

Saved in:
Bibliographic Details
Published inNanomedicine (London, England) Vol. 13; no. 16; pp. 2037 - 2050
Main Authors Oliveira, Catarina, Neves, Nuno M, Reis, Rui L, Martins, Albino, Silva, Tiago H
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.08.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To produce marine-origin nanoparticles (NPs) aiming to develop more effective and tolerated therapies for breast cancer. NPs based in two marine-origin polymers (fucoidan and chitosan) were prepared by polyelectrolyte complexation, for the delivery of an antitumor drug model (gemcitabine [Gem]). Final formulation resulted in stable NPs around 115-140 nm in size and with a polydispersity index less than 0.2. Gem was encapsulated at a maximum entrapment efficiency of 35-42%. Drug-release studies demonstrated that around 84% of Gem is released within 4 h. Cytotoxicity results of Gem-loaded NPs showed increased toxicity (around 25%) when compared with free Gem. The drug-loaded NPs present increased toxicity over human breast cancer cells without increasing toxic effects over endothelial cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1743-5889
1748-6963
1748-6963
DOI:10.2217/nnm-2018-0004